Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Latest filing published 02 Oct 2026 for Gilead Sciences, INC., €1.6M. Read the official filing
Filing timeline
BuySaleDaniel Patrick O'Day
Insider track record
Disclosed buys
0
Disclosed sells
16
Signal history
Daniel Patrick O'Day: trading record in brief
All filings by Daniel Patrick O'Day on record concern Gilead Sciences, Inc., in the capacity of chief executive. The record holds 47 filings, for trades running from 26 January 2022 to 1 October 2026.
On the market, this insider has only sold: 16 sales, €11.8M in total. Besides market trades, the filings include 8 share grants and 23 option exercises. Since January 2026: no purchases and 8 sales on the market.
The newest entry dates from 2 October 2026: an open-market sale of €1.6M, in Gilead Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel Patrick O'Day
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
12,000 shares@ US$147.719Common StockSEC:0001638643-26-000035:0
3,000 shares@ US$148.6265Common StockSEC:0001638643-26-000035:1
8,780 sharesCommon StockSEC:0001638643-26-000033:0
4,230 shares@ US$144.810.0003% mcap2.3% of flowCommon StockSEC:0001638643-26-000033:1
6,700 shares@ US$129.65830.0005% mcap3.2% of flowCommon StockSEC:0001638643-26-000028:0
600 shares@ US$131.34330.0000% mcap0.3% of flowCommon StockSEC:0001638643-26-000028:2
7,700 shares@ US$130.80220.0005% mcap3.7% of flowCommon StockSEC:0001638643-26-000028:1
4,213 sharesCommon StockSEC:0001638643-26-000024:1
8,779 sharesCommon StockSEC:0001638643-26-000024:0
6,950 shares@ US$128.78770.0005% mcap3.3% of flowCommon StockSEC:0001638643-26-000020:0
10,000 shares@ US$136.81625.1% of flowCommon StockSEC:0001638643-26-000018:0
20,026 sharesCommon StockSEC:0001638643-26-000014:0
38,396 shares0Common StockSEC:0001638643-26-000012:0
115,640 shares@ US$66.0127.7% of flowCommon StockSEC:0001638643-26-000010:0
131,675 shares0Common StockSEC:0001638643-26-000008:0
5,032 shares@ US$139.54410.0004% mcap2.5% of flowCommon StockSEC:0001638643-26-000006:0
115,640 shares@ US$66.010.0040% mcap27.8% of flowCommon StockSEC:0001638643-26-000004:0
10,000 shares@ US$124.82720.0007% mcap4.5% of flowCommon StockSEC:0001638643-25-000017:0
10,426 sharesCommon StockSEC:0001638643-25-000015:0
3,212 shares@ US$125.91160.0002% mcap1.5% of flowCommon StockSEC:0001638643-25-000013:0
7,978 shares@ US$119.53710.0005% mcap3.5% of flowCommon StockSEC:0001638643-25-000011:0
8,039 shares@ US$111.47033.3% of flowCommon StockSEC:0001638643-25-000009:0
10,427 sharesCommon StockSEC:0001638643-25-000007:0
10,000 shares@ US$113.630.0006% mcap4.2% of flowCommon StockSEC:0001638643-25-000005:0
1,655 shares@ US$113.16780.7% of flowCommon StockSEC:0001127602-25-019732:0
25 of 47 declarations
